Sr. Scientist
Translational Biomarkers
Posted on 3/22/2024
Arrowhead Pharmaceuticals

201-500 employees

RNAi-based gene-silencing therapeutics
Company Overview
Arrowhead Pharmaceuticals stands out in the biopharmaceutical industry through its focused application of RNA interference (RNAi) mechanisms to develop targeted therapies for genetic diseases, exemplified by its candidate plozasiran aimed at reducing ApoC3 protein levels to manage severe hypertriglyceridemia. The company's proprietary TRiM platform demonstrates a competitive edge by enabling tissue-specific gene silencing, which has shown promise in early clinical trials, such as the AROAPOC3-2001 study, to improve lipid levels safely and effectively. Arrowhead's approach to drug development not only streamlines manufacturing and potentially reduces costs but also positions the company as a leader in RNAi therapeutics, with ongoing research that could transform treatment paradigms for patients with lipid disorders.
Biotechnology

Company Stage

N/A

Total Funding

$899.9M

Founded

2004

Headquarters

Pasadena, California

Growth & Insights
Headcount

6 month growth

10%

1 year growth

32%

2 year growth

63%
Locations
Madison, WI, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
Desired Skills
Communications
CategoriesNew
Lab & Research
Interdisciplinary Research
Life Sciences
Requirements
  • PhD and at least 5 or more years of industrial experience applying translational biomarker technologies for discovery and/or clinical research
  • Extensive experience in technical development, validation, and implementation of cellular and soluble biomarker assays in clinical studies
  • Excellent organization, written and verbal communication skills
  • Collaborative spirit and ability to thrive in a fast-paced and matrixed work environment
Responsibilities
  • Design, develop, and execute robust \